**Summary of Reckitt Q3 2025 Trading Update**
Reckitt Benckiser Group PLC reported strong Q3 2025 results, with **Core Reckitt** delivering **6.7% like-for-like (LFL) net revenue growth**, driven by robust performance in **Emerging Markets** (+15.5% LFL) and a return to growth in **Developed Markets** (Europe +0.8%, North America +1.3%). The company highlighted **volume improvements** (+3.4% in Core Reckitt) and the strength of its **Powerbrands**, particularly in **Intimate Wellness** (+13.5% LFL) and **Germ Protection** (+9.2% LFL).
**Key Highlights**
1. **Emerging Markets** led growth, with China delivering double-digit gains across categories like **Dettol**, **Durex**, and **Intima**. India saw low single-digit growth due to a GST regime shift, but remains high single-digit YTD.
2. **Europe** returned to growth (+0.8% LFL) with innovations driving premiumisation and volume recovery.
3. **North America** grew +1.3% LFL, excluding seasonal OTC brands, with **Lysol** and **Neuriva** performing well.
4. **Mead Johnson Nutrition** rebounded strongly (+22.0% LFL) after recovering from the 2024 tornado impact.
5. **Essential Home** declined (-4.9% LFL) due to weak performance in Brazil and U.S. Air Care, with divestment expected by December 2025.
**Strategic Progress**
**£1 billion share buyback** commenced, with the first £250m tranche completed.
Balanced growth algorithm with volume (+3.4%) and price/mix (+3.3%) contributions.
Innovations like **Mucinex Rapid+Clear** and **Durex Intensity** drove growth.
**Outlook**
FY 2025 guidance maintained**Group LFL net revenue growth of 3-4%**, with Core Reckitt <mark style="background-color:yellow">above</mark> 4%.
Adjusted operating profit expected to outpace net revenue growth, supported by the **Fuel for Growth** programme.
Adjusted diluted EPS growth anticipated for the year.
Reckitt remains confident in its strategy to deliver sustainable growth as a global leader in consumer health and hygiene.